Minimally Invasive Surgery in Massachusetts

Tecomet, Inc. is a global precision contract manufacturer founded in 1963 and headquartered in Woburn, Massachusetts, serving the medical device, orthopedic, and minimally invasive surgical markets. With 2,000+ employees across 14 manufacturing campuses in five countries, Tecomet generates approximately $678.9 million in annual revenue. The company is recognized as the world's largest orthopedic contract manufacturer, delivering end-to-end manufacturing solutions from design prototyping through full-scale production. Tecomet specializes in complex, high-precision products utilizing proprietary technologies including photochemical etching, precision machining, additive manufacturing, net shape forging, casting, laser and electron beam welding, and robotic finishing. Core offerings include orthopedic implants (hip, knee, shoulder, spine, trauma & extremities), precision surgical instruments, minimally invasive surgical components, and specialized cases and trays. The company provides comprehensive services encompassing innovation and design consulting, rapid prototyping, packaging and sterile cleanroom assembly, and full production support. Its collaborative approach and rigorous quality standards make it a preferred partner for leading medical device OEMs seeking scalable, innovative manufacturing solutions for orthopedic and surgical device products.

Tegra Medical is a global contract manufacturer specializing in end-to-end production of medical devices. Headquartered in Franklin, Massachusetts, with manufacturing facilities across the United States, Costa Rica, Switzerland, and Asia, the company employs over 1,000 people. Tegra Medical delivers comprehensive manufacturing solutions including design, prototyping, precision production, assembly, packaging, and sterilization for complex metal and plastic components. The company serves multiple therapeutic areas including oncology, orthopedics, cardiology, minimally invasive surgery, ophthalmic, women's health, drug delivery, and robotic-assisted surgery applications. Advanced manufacturing capabilities include Swiss machining, multi-axis milling, injection molding, wire grinding, and precision finishing. Tegra Medical maintains ISO 13485 certification and FDA registration, supported by rigorous quality management systems. The company also operates Quick Wire & Tubing, an e-commerce platform offering in-stock and custom wire, tubing, and secondary processing services for medical device development and prototyping.

Amsel Medical Corporation develops minimally invasive surgical occlusion devices for vessel and tubular structure closure. The company's primary product, SCureClamp™ with Interdigitation Occlusion Technology (iDOT™), is a mechanical surgical clamping device FDA-cleared and CE-marked for closing blood vessels, arteries, veins, and ducts during surgical and interventional procedures. The device employs a unique transfixing mechanism delivered through an 18-gauge needle, providing permanent, non-chemical, non-thermal occlusion similar to hand-sewn transfixion sutures. Key design features include anchoring technology to prevent slippage, accommodation of vessels 2.0–7.0 mm in diameter, and ultrasound-guided deployment. Amsel's SCureClamp targets multiple surgical specialties including vascular surgery, general surgery (bariatric, cardiac, oncology), trauma management, and interventional radiology. In vascular applications, the device addresses limitations of current perforator treatments (lasers, RF, glue, sclerotherapy), which average 75–80% efficacy and lack permanent solutions. Clinical evidence from peer-reviewed publications in the Journal of Vascular Surgery, Surgical Endoscopy, and Journal of Surgical Research demonstrates preclinical efficacy in porcine models. The company is also developing a temporary clamping variant for military trauma applications, specifically targeting non-compressible and junctional hemorrhage in prehospital environments. Amsel Medical was awarded a prestigious U.S. Air Force AFWERX Phase 2 SBIR grant for this development. The company's devices are indicated for use by vein physicians, general surgeons, vascular surgeons, cardiovascular surgeons, interventional radiologists, and military medical personnel. Manufacturing and regulatory compliance align with FDA 510(k) and CE Mark standards.

Viant Medical is a vertically integrated contract manufacturing partner specializing in medical device design, development, and full-scale production. The company operates 25 global locations with 2.3 million square feet of factory space, including 299,000+ square feet of ISO-certified clean room capacity. Viant serves OEMs across multiple clinical markets: orthopedics (instruments, implants, delivery systems, UHMWPE components), surgical technologies (minimally invasive surgery, robotics, endoscopy, ophthalmology, wound care, biopsy, aesthetic surgery), cardiac and interventional devices (overmolding, nitinol tubing, hypotube precision components), drug delivery (auto-injectors, IV sets, connectors, respiratory devices), bioprocessing (containment, transfer, filtration systems), bioelectronics (pain management, sleep apnea, wearables), diagnostics and laboratory products (injection tubes, chromatography tubing), and respiratory/monitoring/patient care (masks, trach tubes, airway tubes, console components). Core manufacturing capabilities include precision metals and metal tubing, medical-grade plastics and silicone molding, extrusions, tooling, automation, device assembly, and finished device services. The company provides end-to-end solutions from prototyping through sterilization and packaging management. Viant emphasizes vertical integration to ensure quality control, reduce supply chain risk, and accelerate time-to-market. The ViaLaunch™ program offers program management support. The company focuses exclusively on medical device manufacturing and maintains operational expertise in complex assembly, overmolding, and materials science.

GI Windows Surgical is a medical technology company specializing in innovative anastomotic technology using self-forming magnets to enable less invasive gastrointestinal surgical procedures. The company's core products—Flexagon™ Self-forming Magnets and Otoloc™ Access System—both FDA 510(k) cleared, facilitate the creation of surgical connections in the GI tract without sutures or staples. This represents the first significant breakthrough in anastomotic procedures in over 40 years. The technology demonstrates superior healing outcomes compared to traditional staplers in preclinical studies and clinical publications, with applications across bariatric, colorectal, and general surgical oncology. The company, founded as a spin-out from Beacon Endoscopic and headquartered in Westwood, Massachusetts, is backed by prominent investors including Johnson & Johnson and has secured significant funding for clinical development and commercialization.